Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North Carolina
Heron Therapeutics (HRTX) announced the relocation of its corporate headquarters from San Diego, California to Cary, North Carolina, effective January 1, 2025. The new headquarters will be located near the Research Triangle Park (RTP), positioning the company within one of the most prominent high-tech R&D parks in the US. The move is strategic as a majority of Heron's Management Team and corporate employees already work from the Cary office.
CEO Craig Collard highlighted that the relocation will centralize operations and resources while facilitating strategic partnerships. The new headquarters will be situated at 100 Regency Forest Drive, Suite 300, Cary, NC 27518. The location provides ample space for growth and expansion within the growing biotech community.
Heron Therapeutics (HRTX) ha annunciato il trasferimento della sua sede centrale da San Diego, California, a Cary, Carolina del Nord, a partire dal 1 gennaio 2025. La nuova sede sarà situata nei pressi del Research Triangle Park (RTP), collocando l'azienda in uno dei parchi di ricerca e sviluppo ad alta tecnologia più importanti degli Stati Uniti. Questo trasferimento è strategico poiché la maggior parte del team di gestione e dei dipendenti aziendali di Heron lavora già dall'ufficio di Cary.
Il CEO Craig Collard ha sottolineato che il trasferimento centralizzerà le operazioni e le risorse, facilitando nel contempo le partnership strategiche. La nuova sede si troverà al 100 Regency Forest Drive, Suite 300, Cary, NC 27518. La posizione offre ampio spazio per la crescita e l'espansione all'interno della fiorente comunità biotecnologica.
Heron Therapeutics (HRTX) anunció la reubicación de su sede corporativa de San Diego, California, a Cary, Carolina del Norte, a partir del 1 de enero de 2025. La nueva sede estará situada cerca del Research Triangle Park (RTP), posicionando a la empresa dentro de uno de los parques de I+D de alta tecnología más destacados de EE. UU. Este movimiento es estratégico, ya que la mayoría del equipo de gestión y los empleados corporativos de Heron ya trabajan desde la oficina de Cary.
El CEO Craig Collard destacó que la reubicación centralizará las operaciones y los recursos, al tiempo que facilitará las asociaciones estratégicas. La nueva sede estará ubicada en 100 Regency Forest Drive, Suite 300, Cary, NC 27518. La ubicación ofrece amplio espacio para el crecimiento y la expansión dentro de la creciente comunidad biotecnológica.
헤론 테라퓨틱스(HRTX)는 2025년 1월 1일부터 샌디에고, 캘리포니아에서 노스캐롤라이나주 캐리로 본사를 이전한다고 발표했습니다. 새로운 본사는 리서치 트라이앵글 파크(RTP) 근처에 위치하게 되어, 미국에서 가장 저명한 고기술 연구개발(R&D) 공원 중 하나에 회사가 자리잡게 됩니다. 이 이전은 헤론의 관리 팀과 기업 직원의 대다수가 이미 캐리 사무소에서 근무하고 있기 때문에 전략적입니다.
CEO 크레이그 콜라드는 이전이 운영 및 자원을 중앙 집중화할 것이라고 강조하며, 전략적 파트너십을 촉진할 것이라고 밝혔습니다. 새로운 본사는 100 Regency Forest Drive, Suite 300, Cary, NC 27518에 위치합니다. 이 장소는 성장하는 생명공학 커뮤니티 내에서 확장 및 성장을 위한 충분한 공간을 제공합니다.
Heron Therapeutics (HRTX) a annoncé le déménagement de son siège social de San Diego, Californie, à Cary, Caroline du Nord, à compter du 1er janvier 2025. Le nouveau siège sera situé près du Research Triangle Park (RTP), plaçant l'entreprise dans l'un des parcs de recherche et développement technologique les plus importants des États-Unis. Ce déménagement est stratégique car la majorité de l'équipe de direction et des employés de l'entreprise de Heron travaille déjà depuis le bureau de Cary.
Le PDG Craig Collard a souligné que ce déménagement centralisera les opérations et les ressources tout en facilitant les partenariats stratégiques. Le nouveau siège sera situé au 100 Regency Forest Drive, Suite 300, Cary, NC 27518. L'emplacement offre suffisamment d'espace pour la croissance et l'expansion au sein de la communauté biotechnologique en pleine expansion.
Heron Therapeutics (HRTX) hat die Verlegung seines Unternehmenssitzes von San Diego, Kalifornien, nach Cary, North Carolina, bekannt gegeben, die am 1. Januar 2025 in Kraft tritt. Der neue Hauptsitz wird in der Nähe des Research Triangle Park (RTP) errichtet, wodurch das Unternehmen in einem der prominentesten High-Tech-F&E-Parks in den USA positioniert wird. Der Umzug ist strategisch, da der größte Teil des Management-Teams und der Unternehmensmitarbeiter von Heron bereits vom Büro in Cary arbeitet.
CEO Craig Collard betonte, dass der Umzug die Abläufe und Ressourcen zentralisieren und strategische Partnerschaften erleichtern wird. Der neue Hauptsitz befindet sich in der 100 Regency Forest Drive, Suite 300, Cary, NC 27518. Der Standort bietet ausreichend Raum für Wachstum und Erweiterung innerhalb der sich entwickelnden Biotech-Community.
- Strategic relocation to a major biotech hub (Research Triangle Park)
- Operational efficiency through centralization of management and corporate staff
- Access to growth opportunities in a prominent R&D environment
- None.
Insights
This headquarters relocation to North Carolina's Research Triangle Park (RTP) region demonstrates strategic cost optimization and operational consolidation, but carries minimal immediate financial impact. The move from high-cost San Diego to lower-cost Cary could yield meaningful operational savings through reduced overhead and real estate expenses. RTP's established biotech ecosystem offers potential benefits: access to specialized talent, proximity to academic institutions and opportunities for strategic partnerships. However, the relocation's timing (January 2025) and lack of specific financial details suggest this is primarily an administrative change rather than a market-moving event.
For context, biotech companies relocating to RTP typically save
"We are excited to move our headquarters to
The new address for Heron's corporate headquarters is 100 Regency Forest Drive, Suite 300,
About Heron Therapeutics, Inc.
Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard-of-care for acute care and oncology patients. For more information, visit www.herontx.com.
Forward-looking Statements
This news release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Heron cautions readers that forward-looking statements are based on management's expectations and assumptions as of the date of this news release and are subject to certain risks and uncertainties that could cause actual results to differ materially. Therefore, you should not place undue reliance on forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q, and in our other reports filed with the Securities and Exchange Commission, including under the caption "Risk Factors." Forward-looking statements reflect our analysis only on their stated date, and Heron takes no obligation to update or revise these statements except as may be required by law.
Investor Relations and Media Contact:
Ira Duarte
Executive Vice President, Chief Financial Officer
Heron Therapeutics, Inc.
iduarte@herontx.com
858-251-4400
View original content to download multimedia:https://www.prnewswire.com/news-releases/heron-therapeutics-announces-corporate-headquarters-relocation-to-cary-north-carolina-302338528.html
SOURCE Heron Therapeutics, Inc.
FAQ
When will Heron Therapeutics (HRTX) complete its headquarters relocation to Cary, NC?
What is the new address of Heron Therapeutics (HRTX) headquarters?
Why is Heron Therapeutics (HRTX) moving its headquarters to Cary, NC?
How will the HRTX headquarters relocation benefit the company's operations?
